These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Drugs in obesity. Sapeika N S Afr Med J; 1974 Oct; 48(48):2027-30. PubMed ID: 4439101 [No Abstract] [Full Text] [Related]
3. An appraisal of anorexiants in the treatment of obesity. Fineberg SK J Am Geriatr Soc; 1972 Dec; 20(12):576-9. PubMed ID: 4639421 [No Abstract] [Full Text] [Related]
4. Amphetamine: the Janus of treatment for obesity. Bray GA Obes Res; 1994 May; 2(3):282-5. PubMed ID: 16353431 [No Abstract] [Full Text] [Related]
5. Double-blind trial of anorectic agents. Sproule BC Med J Aust; 1969 Feb; 1(8):394-5. PubMed ID: 4889477 [No Abstract] [Full Text] [Related]
6. A new anorectic drug. Benjamin JM Br J Clin Pract; 1968 Aug; 22(8):350-2. PubMed ID: 4885706 [No Abstract] [Full Text] [Related]
7. Activity of anorectic drugs (Amphetamine), amfepramone and UP 507-O4) on two models of obesity in animals [proceedings]. Dumeur G; Hüe B; Lwoff JM; Mouries MA; Tremblay D Br J Pharmacol; 1976 Nov; 58(3):437P. PubMed ID: 990622 [No Abstract] [Full Text] [Related]
9. The case history of a resolution. There oughtn't to be a law. Maddock RK JAMA; 1972 Feb; 219(7):898-9. PubMed ID: 5066674 [No Abstract] [Full Text] [Related]
10. [Study of ethyl-phenyl-aminopropane in the treatment of obesity]. Baylon H; Kreis H; Kleinknecht D Sem Ther; 1964 Mar; 40(3):193-6. PubMed ID: 5878649 [No Abstract] [Full Text] [Related]
11. Evaluation of amphetamine as an appetite depressant. GALLAGHER NI; KNIGHT WA J Chronic Dis; 1958 Aug; 8(2):244-52. PubMed ID: 13563605 [No Abstract] [Full Text] [Related]
12. Use of amphetamines. N Engl J Med; 1971 Feb; 284(5):278-9. PubMed ID: 4395368 [No Abstract] [Full Text] [Related]
13. [Rôle of anorectic agents and other drugs in treatment of obesity]. Laurent LP Vie Med Can Fr; 1972 May; 1(5):491-3. PubMed ID: 4643642 [No Abstract] [Full Text] [Related]
14. [The problem of drug therapy in obesity]. Liebermeister H Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1393-8. PubMed ID: 1030003 [No Abstract] [Full Text] [Related]
15. Abuse of anorexics with special reference to newer substances. Ladewig D; Battegay R Int J Addict; 1971 Mar; 6(1):167-72. PubMed ID: 5135294 [No Abstract] [Full Text] [Related]
16. Double-blind comparison of efficacy, safety, and side effects of Bionamin, phentermine compound, and placebo in the treatment of exogenous obesity. Cohen A; De Felice EA; Leb SM; Fuentes JG; Rothwell KG; Truant AP Curr Ther Res Clin Exp; 1968 Jul; 10(7):323-34. PubMed ID: 4969672 [No Abstract] [Full Text] [Related]
17. Human autonomic pharmacology. XVI. Benzedrine sulfate as an aid in the treatment of obesity. 1938. Lesses MF; Myerson A Obes Res; 1994 May; 2(3):286-92. PubMed ID: 16353432 [No Abstract] [Full Text] [Related]
18. Double-blind trial of anorectic agents. Bell DS Med J Aust; 1969 Mar; 1(11):599-600. PubMed ID: 4889482 [No Abstract] [Full Text] [Related]
19. Use and abuse of appetite-suppressant drugs in the treatment of obesity. Bray GA Ann Intern Med; 1993 Oct; 119(7 Pt 2):707-13. PubMed ID: 8363202 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of obesity by a delayed-action anorexigenic agent checked by gas chromatography]. Junet R; Moayedi S Rev Med Suisse Romande; 1971 Jul; 91(7):503-10. PubMed ID: 5113316 [No Abstract] [Full Text] [Related] [Next] [New Search]